In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

When the gland is removed at a young age, long-term reductions in T-cells-white blood cells that fight germs and disease-are seen in patients. Furthermore, kids without a thymus often have an ...

Thymic carcinoma, a rare cancer, is often associated with poor prognosis in advanced or recurrent stages. However, its rarity ...

The thymus, vital for early life immune development, diminishes with age, increasing susceptibility to immune diseases. Tolerance Bio’s technologies seek to delay this decline and restore thymic ...

We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...

ThymicUK is a support group for people with cancers of the thymus gland. They aim to address the feeling of isolation that can come with a rare disease. They share information and experiences as well ...

His goal is to apply his findings to develop new therapies to promote immunity in cancer patients who receive thymus-­damaging treatments and/or to boost the effectiveness of vaccines in people whose ...

The discovery of a protein’s contribution to the development of T-cells in the spleen and thymus could lead to new treatment strategies for immunodeficiency diseases. Despite its name ...